Exagen reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Exagen using advanced sorting and filters.
Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Q3 | 2024-11-12 | $-0.28 | $-0.29 | 3.45 % |
Q2 | 2024-08-05 | $-0.16 | $-0.35 | 54.3 % |
Q1 | 2024-05-13 | $-0.19 | $-0.36 | 47.2 % |
Q4 | 2024-03-18 | $-0.31 | $-0.43 | 27.9 % |
Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Q3 | 2024-11-12 | $12.51M | $13.56M | -7.77 % |
Q2 | 2024-08-05 | $15.06M | $13.13M | 14.7 % |
Q1 | 2024-05-13 | $14.42M | $13.09M | 10.1 % |
Q4 | 2024-03-18 | $13.77M | $11.56M | 19.1 % |
Exagen (XGN) is scheduled to report earnings on March 17, 2025. The last reported earnings were for reported on November 12, 2024 for Q3.
The Actual EPS was $-0.28, which beat the estimate of $-0.29.
The Actual Revenue was $12.5M, which missed the estimate of $13.6M.
Browse earnings estimates, EPS, and revenue on all stocks.